Patient-centred outcomes in the phase 3 study ARIEL3 of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: post hoc exploratory analyses by BRCA mutation status and patient age
Authors
Colombo, NOza, AM
Lorusso, D
Aghajanian, C
Oaknin, A
Dean, A
Weberpals, JI
Clamp, Andrew R
Scambia, G
Leary, A
Holloway, RW
Gancedo, MA
Fong, PC
Goh, JC
O'Malley, DM
Armstrong, DK
Banerjee, S
Garcia-Donas, J
Swisher, EM
Meunier, J
Cameron, T
Maloney, L
Goble, S
Bedel, J
Coleman, RL
Ledermann, JA
Affiliation
Gynecologic Cancer Program, European Institute of Oncology and University of Milan-Bicocca, Milan, ItalyIssue Date
2019
Metadata
Show full item recordCitation
Colombo N, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Patient-centred outcomes in the phase 3 study ARIEL3 of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: post hoc exploratory analyses by BRCA mutation status and patient age. International Journal of Gynecological Cancer. 2019;29:A28-A9.Journal
International Journal of Gynecological CancerDOI
10.1136/ijgc-2019-ESGO.29Additional Links
https://dx.doi.org/ 10.1136/ijgc-2019-ESGO.29Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/ijgc-2019-ESGO.29